FSC: HIV-Positive Test in Europe

FSC: HIV-Positive Test in Europe

LOS ANGELES — The Free Speech Coalition today issued a statement regarding a confirmed positive test for HIV in Spain.

Their full statement follows:

The Free Speech Coalition has learned of a confirmed positive test for HIV in Spain. The performer had never tested within the PASS database.

Unlike shoots in the U.S. and Canada, productions in Europe do not currently have access to a standardized and unified system such as the PASS database. While FSC-PASS does not have the power to mandate and control a production hold in Europe, we strongly urge that producers and performers in Europe immediately stop filming.

The case in question is not believed to be related to North American productions. We are working with PASS-affiliated testing doctors at CET and TTS, as well as partners in Europe, to determine what risk, if any, might exist for performers in the PASS system.

In regards to EU productions, FSC strongly recommends:

  • That producers and performers immediately engage in a production hold. While FSC has no ability to mandate or control such a hold in Europe, we would urge in the strongest possible terms that production stops for at least 28 days, and up to two months, until the scope of contacts, is known and the performer population can be retested
  • Performers retest with an HIV RNA qualitative test, rather than the less sensitive Europe-standard ELISA antibody test.

In regards to U.S. productions, FSC strongly recommends:

  • Only work with PASS-tested performers.
  • Do not work with anyone beyond the the PASS mandated 14-day test standard.
  • If you are about to work with non-U.S.-based talent, require a new test.
  • If you have worked on a European set, or with a non-PASS-tested performer, within the past two weeks, retest.

FSC-PASS will continue to monitor the situation and is working with PASS-affiliated clinics to determine if there is any increase in incidence for US-based performers in the PASS system.

As a community we urge everyone to be compassionate and considerate of the difficult time the performer who was just diagnosed is going through.

Related:  

Copyright © 2024 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

Bella Rolland Toplines 'The Sex Impulse' From Sweet Sinner

Bella Rolland headlines "The Sex Impulse," the latest release from Mile High Media studio brand Sweet Sinner.

Adult Time Partners With Animation Studio 3DGspot

Adult Time has signed a deal to distribute content on its streaming platform from animation studio 3DGspot.

Willow Ryder, Angelina Diamanti Topline 'Lesbian Neighbor Affairs'

Willow Ryder and Angelina Diamanti headline "Lesbian Neighbor Affairs," from Girlfriends Films.

Cherie DeVille Discusses Doc Johnson Collabs in Vice TV's 'Sex Before the Internet'

2023 XBIZ Performer of the Year Cherie DeVille is featured on Vice TV’s “Sex Before the Internet,” discussing her Doc Johnson celebrity strokers in the episode “Sex Toy Empire.”

SINematica Names Silvia Dellai 'Most Valuable Performer' for April

SINematica has crowned Czech-Italian star Silvia Dellai as Most Valuable Performer for the month of April, with a spotlight scene opposite Yannick Shaft and Erik Everhard.

Hazel Grace Debuts New Membership Site InMelanin

Hazel Grace has launched her new membership site, InMelanin.

Vixen Media Group Debuts 2nd Season of 'Hotel Vixen'

Vixen Media Group (VMG) has launched the second season of its Greece-set series "Hotel Vixen."

Ada Lapiedra Toplines Private's 'Hot Girls in Hot Cars'

Ada Lapiedra headlines "Hot Girls in Hot Cars," the latest release from Private.

Anna de Ville Headlines Proxy Paige's 'Gape Expectations'

Anna de Ville headlines director Proxy Paige's "Gape Expectations," from Evil Angel.

Adult Time's 'Up Close' Series Spotlights Dharma Jones

Dharma Jones is spotlighted in the latest installment of Adult Time's "Up Close," with Mike Mancini.

Show More